Fund HoldingsForesite Capital Management VI LLC

Total Portfolio Value
$642.58M
Total Bought
$202.20M
Total Sold
$61.11M
Net Transaction
+$141.09M
Filing Period:
Securities
SharesValue ($K)
Q1 2026
Q2 2026
Change
Q1 2026
Q2 2026
Weight (%)
Change
Seaport Therapeutics, Inc.01,779,521+1,779,521038,6516.02%+38,651
Parabilis Medicines, Inc.0999,044+999,044027,3444.26%+27,344
ALUMIS INC.4,247,6704,247,670093,576119,52918.60%+25,953
Celldex Therapeutics, Inc.(CLDX)315,913879,713+563,80010,02132,7345.09%+22,713
GH Research PLC(GHRS)315,492940,493+625,0014,43625,2803.93%+20,845
CG Oncology, Inc.(CGON)2,221,4742,369,574+148,100150,349168,35826.20%+18,009
Jade Biosciences, Inc.320,000886,667+566,6674,49619,7023.07%+15,206
Denali Therapeutics Inc.(DNLI)1,209,9711,396,771+186,80023,23135,9255.59%+12,694
AGIOS PHARMACEUTICALS, INC.(AGIO)525,000785,000+260,00017,76129,1314.53%+11,371
Beam Therapeutics Inc.(BEAM)0330,000+330,000011,3261.76%+11,326
ArriVent BioPharma, Inc.(AVBP)0301,341+301,341010,4691.63%+10,469
Hinge Health, Inc.(HNGE)220,400220,40008,49918,2932.85%+9,795
Aura Biosciences, Inc.(AURA)01,333,334+1,333,33409,4671.47%+9,467
AtaiBeckley Inc.(ATAI)2,750,0002,750,00009,73514,4932.26%+4,758
Kymera Therapeutics, Inc.(KYMR)146,332146,332012,18816,7802.61%+4,592
Research Alliance Corp III0300,000+300,00003,2100.50%+3,210
Kailera Therapeutics, Inc.037,500+37,50008260.13%+826
Corvus Pharmaceuticals, Inc.(CRVS)1,831,2331,831,233026,79127,3594.26%+568
Crinetics Pharmaceuticals, Inc.(CRNX)212,010212,01007,7007,9331.23%+233
Disc Medicine, Inc.(IRON)0970+9700710.01%+71
Zura Bio Ltd(ZURA)450,000450,00002,6782,6550.41%-22
Minerva Neurosciences, Inc.(NERV)1,986,6001,985,584-1,01611,96911,0201.71%-949
Verastem, Inc.(VSTM)3,146,6313,146,631016,67712,0201.87%-4,657
OnKure Therapeutics, Inc.(OKUR)1,445,7830-1,445,7835,9860-5,986
Centessa Pharmaceuticals plc1,364,0190-1,364,01954,1790-54,179
Page 1 of 1
Foresite Capital Management VI LLC — 13F Holdings — Q2 2026 | TickerTrail